Decoding the therapeutic promise of Solanum trilobatum in oral submucous fibrosis: a network pharmacology, docking, and bioactivity study
) and anti-inflammatory activities, with the highest activity observed at 500 µg/mL. These findings highlight the potential of S. trilobatum as a promising candidate for OSF therapy, but warranting further experimental studies.
Authors
- M. Anusha
- Rajkumari Sriraman (ORCID: https://orcid.org/0000-0001-9046-4121)
- Balasubramaniam Am
- Saranya Ramsridhar (ORCID: https://orcid.org/0000-0002-7965-9021)
- Chandini Rajkumar
- Joe Rex Brilient
- Vishnu Priya Veeraraghavan
Institutions
- Sathyabama Institute of Science and Technology (IN)
- Saveetha University (IN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-04-16
- DOI
- https://doi.org/10.1038/s41598-026-46122-8
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00